Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.24 SEK | +1.82% | -1.32% | -39.46% |
Apr. 26 | Q-Linea AB Receives FDA 510(k) Clearance for the ASTar® System | CI |
Mar. 13 | Q-linea AB Presents Strong ASTar Results At AMCLI | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-39.46% | 24.02M | |
-41.07% | 2.95B | |
+18.54% | 1.88B | |
-1.05% | 1.63B | |
+34.11% | 1.34B | |
-16.83% | 959M | |
-22.64% | 888M | |
+7.66% | 842M | |
-25.83% | 623M | |
+10.38% | 513M |
- Stock Market
- Equities
- QLINEA Stock
- News Q-linea AB
- Transcript : Q-linea AB, Q4 2023 Earnings Call, Feb 27, 2024